ECDC study shows that communication around the benefit and risk balance of vaccination requires a mix of different communication approaches to ensure impact across multiple audiences.
Increase in pertussis cases in EU/EEA: infants under six months of age at the highest risk
During 2023 and until April 2024, EU/EEA countries have reported nearly 60 000 cases of pertussis, a more than 10-fold increase compared to 2022 and 2021.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 June 2024 and includes updates on SARS-CoV-2 variant classification, cholera, out-of-season increase in norovirus, seasonal surveillance on West Nile virus infections, Middle East respiratory syndrome coronavirus (MERS-CoV), influenza A(H5N2), Oropouche virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
ECDC is following reports from several European Union and European Economic Area (EU/EEA) countries of substantial increases in the detection of parvovirus B19 (B19V).
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.